|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | MoO_x-based catalysts for the oxidative dehydrogenation (ODH) of ethane to ethylene Influence of vanadium and phosphorus on physicochemical and catalytic properties显示文摘 | Haddad N Bordes-Richard E Barama A | | 0，，3： | 1 |
| 2 | Hydroisornerization of n- heptane and dehydration of 2 -propanol on MoO2 (Hx) ae catalysts 显示文摘 | Benaddaa A Katriba A Barama A | 2003 | Applied catalysis A: General2003，251，： | 1 |
| 3 | Cyp3A4, Cyp3AS, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients 显示文摘 | Roy JN Barama A Poirier C | 2006 | Pharmacogenet C enomics2006，16，9： | 1 |
| 4 | MoOx-based catalysts for the oxidative dehydrogenation(ODH) of ethane to ethylene influence of vanadium and phosphorus on physicochemical and catalytic properties显示文摘 | Haddad N Bordes Richard E Barama A | 2009 | Catalysis Today2009，142，34： | 1 |
| 5 | Characterization and activity in dry reforming of methane on NiMgI Al and NilMgO catalysts显示文摘 | DJAIDJA A Lms S KIENNEMANN A BARAMA A | 2006 | Catal Today2006，113，19： | 1 |
| 6 | CYP3A4, YP3AS,and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients显示文摘 | Roy JN Barama A Poirier C ct al | 2006 | Pharmacogenet C enomics2006，16，65： | 1 |
| 7 | Cyp3A4,Cyp3A5,and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients显示文摘 | ROY J N BARAMA A POIRIER C | 2006 | Pharmacogenet Genomics2006，16，9： | 1 |
| 8 | Cyp3A4,Cyp3A5,and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients显示文摘 | Roy J N Barama A Poirier C | 2006 | Pharmacogenet Genomics2006，16，9： | 1 |
| 9 | Effect of recipient sensitization( peak PRA) on graft outcome in haploidentical living related kidney transplants 显示文摘 | BARAMA A OZA U PANEK R | 2000 | Clin Transplant2000，14，： | 1 |
| 10 | CYP3A4, YP3A5, and MDR-1 genetic influences on tacrolimus pharmacokineties in renal transplant recipients 显示文摘 | Roy JN Barama A Poirier C | 2006 | Pharmacogenet Genomics2006，16，9： | 1 |
| 11 | CYP3A4, CYP3A5, and MDR-1 genetic influences on tacroli- mus pharmacokinetics in renal transplant recipients显示文摘 | Roy JN Barama A Poirier C | 2006 | Pharmacogenet Genomics2006，16，9： | 1 |
| 12 | CYP3A4,CYP3A5,and MDR- 1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients显示文摘 | Roy JN Barama A Poirier C | 2006 | Pharmacogenet Genomics2006，16，9： | 1 |
| 13 | CYP3A4, CYP 3A5, and MDR- 1 genetic influences on Tacrolimus pharmacokinetics in renal transplant recipients 显示文摘 | Roy JN Barama A Poirier C | 2003 | Clin Pharmacol Ther2003，74，： | 1 |
| 14 | The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet显示文摘 | Nakano H Nagasaki H Barama A | | 0，，03： | 1 |
| 15 | Absorption Profiling of cyclosporine therapy for de nove kidney transplantation:a prospective,randomized study comparing sparse sampling to trough monitoring显示文摘 | Perner F Beauregard-Zollinger L | 2000 | Transplantation2000，69，8： | 1 |
| 16 | The effects of n-acetylcystenine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet显示文摘 | Nakano H Nagasaki H Barama A | 1997 | Hepatology1997，26，： | 1 |
| 17 | CYP3A4,CYP3A5,and MDR‐1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients显示文摘 | Roy JN Barama A Poirier C | | 0，，09： | 1 |
| 18 | Cyp3A4,Cyp3A5 and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients显示文摘 | Roy JN Barama A Poirier C | 2006 | Pharmaeogenetics and Genomics2006，16，9： | 1 |
| 19 | Renal cell carcinoma in kidney allografts:a case series from a single center显示文摘 | Barama A St-Louis G Nicolet V | 2005 | Am J Transplant2005，5，12： | 1 |
| 20 | Cyp3A4,Cyp3A5,and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients显示文摘 | ROY J N BARAMA A POIRIER C | 2006 | Pharmacogenet Genomics2006，16，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员